- Home
- GSIW vs IMNN Comparison
GSIW vs IMNN Comparison
Compare GSIW & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- IMNN
- Stock Information
- Founded
- GSIW 2016
- IMNN 1982
- Country
- GSIW Hong Kong
- IMNN United States
- Employees
- GSIW N/A
- IMNN N/A
- Industry
- GSIW
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- GSIW
- IMNN Health Care
- Exchange
- GSIW Nasdaq
- IMNN Nasdaq
- Market Cap
- GSIW 10.5M
- IMNN 12.2M
- IPO Year
- GSIW 2023
- IMNN 1985
- Fundamental
- Price
- GSIW $0.57
- IMNN $0.84
- Analyst Decision
- GSIW
- IMNN Strong Buy
- Analyst Count
- GSIW 0
- IMNN 2
- Target Price
- GSIW N/A
- IMNN $20.50
- AVG Volume (30 Days)
- GSIW 156.5K
- IMNN 191.0K
- Earning Date
- GSIW 12-31-2024
- IMNN 11-07-2024
- Dividend Yield
- GSIW N/A
- IMNN N/A
- EPS Growth
- GSIW N/A
- IMNN N/A
- EPS
- GSIW N/A
- IMNN N/A
- Revenue
- GSIW $1,408,469.00
- IMNN N/A
- Revenue This Year
- GSIW N/A
- IMNN N/A
- Revenue Next Year
- GSIW N/A
- IMNN N/A
- P/E Ratio
- GSIW N/A
- IMNN N/A
- Revenue Growth
- GSIW N/A
- IMNN N/A
- 52 Week Low
- GSIW $0.53
- IMNN $0.48
- 52 Week High
- GSIW $15.99
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- GSIW 36.17
- IMNN 50.04
- Support Level
- GSIW $0.55
- IMNN $0.80
- Resistance Level
- GSIW $0.64
- IMNN $0.88
- Average True Range (ATR)
- GSIW 0.06
- IMNN 0.05
- MACD
- GSIW 0.04
- IMNN 0.01
- Stochastic Oscillator
- GSIW 16.67
- IMNN 41.75
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.